There was a time when erectile dysfunction was a dark secret that stayed very much in the bedroom. Not any more.

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

EUROPEAN COMMISSION PRESIDENT Ursula von der Leyen is set to travel to Strasbourg, France today to address MEPs before a ...